Vanda Pharmaceuticals Inc. Earnings Conference Call (Q4 2012)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Feb 12 Calls Today's Calls

Call Details Vanda Pharmaceuticals Inc. Earnings Conference Call (Q4 2012) Scheduled to start Tue, Feb 12, 2013, 10:00 am Eastern -- this event is ongoing now-- Listen to the ongoing live event audio stream About Vanda Pharmaceuticals Inc (NasdaqGM:VNDA) Other Calls  Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of clinical-stage products for various central nervous system disorders. Its lead product includes Fanapt for the acute treatment of schizophrenia in adults. The company is developing Tasimelteon, which is in the orphan designation status for the treatment of non-24 hour sleep/wake disorder in blind individuals without light perception. It is also developing Tasimelteon in Phase II trials for the treatment of depression. The company was incorporated in 2002 and is headquartered in Rockville, Maryland. More Info: Quote | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings